Trade Harrow Health, Inc. - HROW CFD

Add to favourite

37.60

0.4%

0.21

Low: 37.22

High: 38.03

Market Trading Hours* (UTC) Opens on Thursday at 14:30

Mon - Fri: 14:30 - 21:00

Summary
Historical Data

Trading сonditions

Spread

0.21

Long position overnight fee

-0.024318%

Short position overnight fee

0.002096%

Overnight fee time

22:00 (UTC)

Min traded quantity

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	37.75
Open	37.95
1-Year Change	290.03%
Day's Range	37.22 - 38.03

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Dec 11, 2024	37.60	-0.37	-0.97%	37.97	38.14	37.20
Dec 10, 2024	37.75	-1.38	-3.53%	39.13	40.55	37.45
Dec 9, 2024	39.87	0.46	1.17%	39.41	40.41	38.75
Dec 6, 2024	39.13	1.62	4.32%	37.51	39.24	37.40
Dec 5, 2024	37.35	0.15	0.40%	37.20	37.95	36.60
Dec 4, 2024	38.00	-1.19	-3.04%	39.19	39.87	37.73
Dec 3, 2024	39.92	-1.71	-4.11%	41.63	41.63	38.87
Dec 2, 2024	41.79	0.47	1.14%	41.32	42.05	39.97
Nov 29, 2024	41.75	-0.40	-0.95%	42.15	42.61	40.95
Nov 27, 2024	42.41	0.83	2.00%	41.58	43.61	41.58
Nov 26, 2024	42.17	1.21	2.95%	40.96	42.40	40.96
Nov 25, 2024	41.98	-1.23	-2.85%	43.21	43.21	40.56
Nov 22, 2024	42.80	-1.15	-2.62%	43.95	44.32	42.62
Nov 21, 2024	43.81	1.31	3.08%	42.50	44.19	41.98
Nov 20, 2024	42.36	2.37	5.93%	39.99	42.40	39.66
Nov 19, 2024	39.62	2.40	6.45%	37.22	39.84	37.07
Nov 18, 2024	37.86	-1.14	-2.92%	39.00	39.10	36.95
Nov 15, 2024	38.93	-3.62	-8.51%	42.55	42.55	38.31
Nov 14, 2024	42.80	1.74	4.24%	41.06	46.18	38.96
Nov 13, 2024	51.75	1.77	3.54%	49.98	53.82	49.88

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Harrow Health, Inc. Company profile

About Harrow Health Inc

Harrow Health, Inc. is an ophthalmic-focused healthcare company. The Company owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical business, and Visionology, a direct-to-consumer eye care subsidiary focused on chronic eye disease. The Company holds non-controlling equity positions in Eton Pharmaceuticals, Surface Ophthalmics and Melt Pharmaceuticals. The Company also owns royalty rights in four clinical stage drug candidates, which are being developed by Surface Ophthalmics and Melt Pharmaceuticals.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Harrow Health Inc revenues increased 48% to $72.5M. Net loss applicable to common stockholders increased from $3.4M to $18.5M. Revenues reflect Product sales, net increase of 43% to $69.1M, Other revenues increase from $392K to $3.4M. Higher net loss reflects Investment losses from Eton Pharmaceutic decrease from $3.3M (income) to $10.1M (expense), Selling.